loading page

Early Failure after Non-resectional Mitral Valve repair with Artificial Chordae
  • Ryan Moore,
  • Per Wierup,
  • A. Marc Gillinov
Ryan Moore
Cleveland Clinic
Author Profile
Per Wierup
Cleveland Clinic Department of Thoracic and Cardiovascular Surgery
Author Profile
A. Marc Gillinov
Cleveland Clinic
Author Profile

Peer review status:Published

15 May 2020Submitted to Journal of Cardiac Surgery
19 May 2020Submission Checks Completed
19 May 2020Assigned to Editor
22 May 2020Reviewer(s) Assigned
27 May 20201st Revision Received
06 Jun 2020Assigned to Editor
06 Jun 2020Submission Checks Completed
06 Jun 2020Review(s) Completed, Editorial Evaluation Pending
06 Jun 2020Editorial Decision: Revise Minor
17 Jun 20202nd Revision Received
18 Jun 2020Submission Checks Completed
18 Jun 2020Assigned to Editor
18 Jun 2020Review(s) Completed, Editorial Evaluation Pending
20 Jun 2020Editorial Decision: Accept
28 Jul 2020Published in Journal of Cardiac Surgery. 10.1111/jocs.14817

Abstract

Severe recurrent mitral regurgitation (MR) within 1 year of mitral valve repair is usually attributed to a technical issue with the original repair procedure. However, when artificial chordae are employed to correct mitral valve prolapse, ventricular remodeling (i.e. decreased ventricular size) can lead to recurrent prolapse and valve dysfunction. To highlight this phenomena, we present 2 patients who experienced early failure after undergoing mitral valve repair with artificial chordae.